Avaliação da resposta à terapia antirretroviral de resgate contendo antagonista do correceptor CCR5 em pessoas vivendo com HIV/AIDS

Cabral, Gabriela Bastos.
São Paulo; s.n; 2014. 111 p.
Tese em Português | LILACS, SES-SP, SESSP-CTDPROD, SES-SP, SESSP-ACVSES, SESSP-TESESESSP, SES-SP | ID: biblio-1083385

Documentos relacionados

  1. The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus.
  2. Co-receptor tropism and genetic characteristics of the V3 regions in variants of antiretroviral-naive HIV-1 infected subjects.
  3. Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana.
  4. Correlating HIV tropism with immunological response under combination antiretroviral therapy.
  5. Early Initiation of Antiretroviral Therapy Preserves the Metabolic Function of CD4+ T Cells in Subtype C Human Immunodeficiency Virus 1 Infection.
  6. Adherence to antiretroviral therapy and changes in body composition in people living with HIV and AIDS
  7. Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study.
  8. Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy.
  9. Virological failure of patients on maraviroc-based antiretroviral therapy.
  10. Partial HIV C2V3 envelope sequence analysis reveals association of coreceptor tropism, envelope glycosylation and viral genotypic variability among Kenyan patients on HAART.